AQR Capital Management
PASG icon

AQR Capital Management’s Passage Bio PASG Stock Holding History

AQR Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,570
Closed -$74K – 2285
2022
Q2 		$74K Sell
1,570
-4,849
-76% -$226K ﹤0.01% 2114
2022
Q1 		$398K Buy
6,419
+5,837
+1,003% +$481K ﹤0.01% 1893
2021
Q4 		$74K Buy
+582
New +$95K ﹤0.01% 2169

Other funds holding PASG

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

AQR Capital Management's PASG Position: Q3 2022 in Review

AQR Capital Management sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 1,570 shares — an estimated $74K sold.

AQR Capital Management first reported a position in PASG in Q4 2021 and held it in 3 quarters. The position peaked at $398K in Q1 2022. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

  • AQR Capital Management reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
  • AQR Capital Management sold 1,570 Passage Bio shares in Q3 2022, an estimated $74K.
  • AQR Capital Management first reported a position in Passage Bio in Q4 2021 and held it in 3 quarters.
  • AQR Capital Management's Passage Bio position peaked at $398K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.